KLSE (MYR): KAREX (5247)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.83
Today's Change
-0.015 (1.78%)
Day's Change
0.83 - 0.85
Trading Volume
389,800
Date | Type | Old | New | View |
---|
By the end of the first half of the financial year 2024 (28 Feb 2024), the FDA (Food and Drug Administration) of US should have approved the new 001 condoms to be exported to US. The price of Karex will move north.
2023-11-21 17:08
Sold all at RM0.690 and RM0.685. Got to follow the bears. I shifted to poultry counter LHI (Lay Hong International).
2023-11-22 19:13
001 condoms are by karex? I thought there are by Okamoto. One condom released a Graphene condom 1 month ago is US
2023-11-24 15:38
Very good 1st quarter results. Next Monday should rebound with high volume.
2023-11-24 18:59
Posted by xiaoeh > 4 days ago | Report Abuse
Good exit point in technical term Chloe.
Walao...
my technical got a lot of rooms to improve
2023-11-27 21:36
in my watchlist
still expensive to accumulate
waiting @ 0.60-0.65 :)
2024-01-19 12:31
I went in today (2 Feb 2024). There is nothing much that I could do now. Just wait until end of February to see whether its quarter results is good enough or not. Bears are in full control now.
2024-02-02 16:02
From a sleepy counter, become an active counter. Don't know what to expect.
2024-02-02 16:18
The long tail below the body is indicative of sellers trying to push the price down by a significant amount but the buyers manage to push it back up. The buyers do this to show a definitive buying strength which will lead to an increase in price, going forward.
2024-02-03 20:48
wasted
look for cheap now even more expensive
good stuff won't get cheap
it happened many times 😂
2024-02-06 15:24
KAREX is riding on the strong growth in the condom industry, focusing on high-margin products which will take its profitability to a higher level. It is penetrating high-growth markets with premium offerings backed by innovation and strict compliance with international standards. We project its earnings to double in FY24, followed by another 88% surge in FY25. We initial coverage on KAREX with an OUTPERFORM rating and a TP of RM1.00.
Kenanga Research
2024-02-13 18:23
Read and listen to the words from Karex CEO. "Karex pivots beyond latex condoms". Results have been better quarter over quarter for 5 consecutive quarters. He said 26 Feb 2024 will also be better than the previous quarter. New products are lubricant and gloves.
2024-02-14 14:36
Please understand that RM0.87 at this moment is not Karex all time high. Its all time high was RM3.10 on 11.3.2016. It is unlike Sunway, MBMR, HUMEIND, etc.
2024-02-14 15:27
Still thinking very hard whether or not I should bet on Karex next Monday, with its 2nd quarter results after 5 pm. Now 0.835 and the highest 0.87.
2024-02-24 00:28
Very, very good 2nd quarter results:
PAT 2nd quarter FY 2024: RM7,324 mil [compared to PAT 2nd quarter FY2023: RM2,025 million, which is an increased of 262% YoY]
PAT 2nd quarter FY 2024: RM7,324 mil [compared to PAT 1st quarter FY2024: RM5,256 million, which is an increased of 39% QoQ]
Hopefully, the operator will help to break the 52-week ATH of RM0.87, starting 27 Feb 2024
2024-02-26 17:26
buy one nasi lemak flavor condom and use tonight. support local manufacturer
2024-02-26 22:11
The heyday of being the sole and top condom manufacturer in Malaysia is over for Karex Bhd. I used to own a significant number of Karex shares, but it saddens me that the management has failed to turn the company around even after many years. I don't believe Karex will recover to its previous highs
2024-02-28 19:25
Agree with Kenanga's analyst with regards to the emphasis on improving margins by the company. However, the focus on premium products is not really feasible cause condom users do not place much importance on the actual quality of the products compared to other consumer staples.
There is no way for the company to bring the sales volume/total sales back to 2016 levels because the competition within the condom market is surging. Despite the recent introduction of abortion laws in the US, there isn't any significant uptick in sales for the US market which is a bit disappointing.
However, there still remains a few tailwinds for the condom market and near-term catalysts for Karex. Such as weaker Ringgit, and the stabilisation of raw material/labour cost. And the diversification/venture into gloves and lubricant products, on top of the company's healthy balance sheet.
My mid-term PT is about RM0.90
2024-02-28 19:34
Consolidation shall finished..
$1.06 kenanga target coming..
KAREX is the largest condom Mfg in the world..
It need to reflect its strength but not below $1 penny world class
2024-03-28 15:16
this stock.. if you look at recent times, low 80+ sen has been a good support level. then slowly inch up closer to results... post result, come back down. cycle repeats.
granted, the results so far has showed major turnaround already .. and the next rerating catalyst will come from the company saying it started mass production for its new product.. and selling big time to the big brand. then.. got chance to see RM1. wait and see ba.
2 months ago
ChloeTai
Still manage to turn from -0.005 to +0.010 and closed at RM0.705. The AGM and 1st quarter results are on next Monday (27 Nov 2023). The target price still maintains at RM0.72.
2023-11-21 17:04